Trials / Completed
CompletedNCT03046576
Prognostic Value of Plasma DPP4 Activity in ST-elevation Myocardial Infarction Patients
The Association Between Plasma DPP4 Activity And Prognosis of Patients With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 625 (actual)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Increased plasma DPP4 activity (DPP4a) could predict both subclinical and new-onset atherosclerosis, and our previous study has found that the DPP4a was significantly lower in MI patients compared with patients having chest pain or unstable angina alone, and DPP4a is associated with no-reflow and major bleeding events in STEMI patients during hospital stay. As no-reflow phenomenon and major bleeding events independently associates with a worse in-hospital and long-term prognosis. One may speculate that the DPP4a is associated with long-term follow-up adverse cardiovascular events in these patients.The hypothesis was tested in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | plasma DPP4 activity | DPP4a was determined by enzymatic assays. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2015-09-30
- Completion
- 2015-09-30
- First posted
- 2017-02-08
- Last updated
- 2017-07-21
Source: ClinicalTrials.gov record NCT03046576. Inclusion in this directory is not an endorsement.